VivoSeq
Other

Old Age

2

Pipeline Programs↗

2

Active Trials↗

1

Companies Involved↗

Old Age is an early-stage landscape with 2 programs across 1 company. The most active players are McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.. 2 therapies are approved.

Intelligence

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

6/100

Mech. Concentration

50/100

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

M

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

1 program

Approved

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved2

Dexmedetomidine

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Esketamine

Wim Janssens

Analysis

Trial Status

3

clinical trials

Enrolling by invitation1 · 33%
Recruiting1 · 33%
Completed1 · 33%

Clinical Trials

Trial Activity

Feasibility and Acceptability of Remote Ischemic Conditioning to Achieve High-Intensity Rehabilitation Effects and Increase Resilience in Older Individuals
Enrolling by invitation·DDuke University·Preclinical·NCT06476288·20 enrolled
Inspiring Seniors Towards Exercise Promotion - 2
Recruiting·EEmory University·Preclinical·NCT07629739·150 enrolled
Effect of Mini-dose Dexmedetomidine-Esketamine Infusion on Sleep Quality in Older Patients Undergoing Knee or Hip Replacement Surgery: A Multicenter Randomized Controlled Trial
Completed·PPeking University First Hospital·Approved·NCT05950646·154 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)